Specifically, we compared whether patients with high and low IL-22BP Expression are differentially distributed between patients with UICC Stage I-II (i.e. tumor growth limited to the primary tumor side and UICC Stage III-IV (i.e. dissemination into locoregional lymph nodes or distant organs). Here, IL22RA2 is linked to neoplasm.